Loading
Only a handful of insider records exist for StageZero Life Sciences Ltd., the last one from 22 December 2020, too few to describe a trend. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
6 of 6 declarations
StageZero Life Sciences Ltd. is a biotechnology company focused on developing early detection tests for cancer. It is listed on the XTSE.